Vitamin D receptor signaling inhibits atherosclerosis in Mice

Frances L. Szeto, Catherine A. Reardon, Dosuk Yoon, Youli Wang, Kari E. Wong, Yunzi Chen, Juan Kong, Shu Q. Liu, Ravi Thadhani, Godfrey S. Getz, Yan Chun Li

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Although vitamin D has been implicated in cardiovascular protection, few studies have addressed the role of vitamin D receptor (VDR) in atherosclerosis. Here we investigate the effect of inacti-vation of the VDR signaling on atherogenesis and the antiatherosclerotic mechanism of vitamin D. Low density lipoprotein receptor (LDLR)-/-/VDR-/- mice exhibited site-specific accelerated atherogenesis, accompanied by increases in adhesion molecules and proinflammatory cytokines in the aorta and cholesterol influx in macrophages. Macrophages showed marked renin up-regulation in the absence of VDR, and inhibition of renin by aliskiren reduced atherosclerosis in LDLR-/-/ VDR-/- mice, suggesting that the renin-angiotensin system (RAS) promotes atherosclerosis in the absence of VDR. LDLR-/- mice receiving LDLR-/-/VDR-/- BMT developed larger lesions than LDLR-/- BMT controls. Moreover, LDLR-/- mice receiving Rag-1 -/-/VDR-/- BMT, which were unable to generate functional T and B lymphocytes, still had more severe atherosclerosis than Rag-1 -/- BMT controls, suggesting a critical role of macrophage VDR signaling in atherosclerotic suppression. Aliskiren treatment eliminated the difference in lesions between Rag-1 -/-/VDR-/- BMT and Rag-1 -/- BMT recipients, indicating that local RAS activation in macrophages contributes to the enhanced atherogenesis seen in Rag-1 -/-/VDR-/- BMT mice. Taken together, these observations provide evidence that macrophage VDR signaling, in part by suppressing the local RAS, inhibits atherosclerosis in mice.

Original languageEnglish (US)
Pages (from-to)1091-1101
Number of pages11
JournalMolecular Endocrinology
Volume26
Issue number7
DOIs
StatePublished - Jul 1 2012

Fingerprint

Calcitriol Receptors
Atherosclerosis
LDL Receptors
Renin-Angiotensin System
Macrophages
Renin
Vitamin D
Macrophage Activation
Aorta
B-Lymphocytes
Up-Regulation
Cholesterol

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

Szeto, F. L., Reardon, C. A., Yoon, D., Wang, Y., Wong, K. E., Chen, Y., ... Li, Y. C. (2012). Vitamin D receptor signaling inhibits atherosclerosis in Mice. Molecular Endocrinology, 26(7), 1091-1101. https://doi.org/10.1210/me.2011-1329
Szeto, Frances L. ; Reardon, Catherine A. ; Yoon, Dosuk ; Wang, Youli ; Wong, Kari E. ; Chen, Yunzi ; Kong, Juan ; Liu, Shu Q. ; Thadhani, Ravi ; Getz, Godfrey S. ; Li, Yan Chun. / Vitamin D receptor signaling inhibits atherosclerosis in Mice. In: Molecular Endocrinology. 2012 ; Vol. 26, No. 7. pp. 1091-1101.
@article{b4bb3097403e4c8b8f99df100a9b9136,
title = "Vitamin D receptor signaling inhibits atherosclerosis in Mice",
abstract = "Although vitamin D has been implicated in cardiovascular protection, few studies have addressed the role of vitamin D receptor (VDR) in atherosclerosis. Here we investigate the effect of inacti-vation of the VDR signaling on atherogenesis and the antiatherosclerotic mechanism of vitamin D. Low density lipoprotein receptor (LDLR)-/-/VDR-/- mice exhibited site-specific accelerated atherogenesis, accompanied by increases in adhesion molecules and proinflammatory cytokines in the aorta and cholesterol influx in macrophages. Macrophages showed marked renin up-regulation in the absence of VDR, and inhibition of renin by aliskiren reduced atherosclerosis in LDLR-/-/ VDR-/- mice, suggesting that the renin-angiotensin system (RAS) promotes atherosclerosis in the absence of VDR. LDLR-/- mice receiving LDLR-/-/VDR-/- BMT developed larger lesions than LDLR-/- BMT controls. Moreover, LDLR-/- mice receiving Rag-1 -/-/VDR-/- BMT, which were unable to generate functional T and B lymphocytes, still had more severe atherosclerosis than Rag-1 -/- BMT controls, suggesting a critical role of macrophage VDR signaling in atherosclerotic suppression. Aliskiren treatment eliminated the difference in lesions between Rag-1 -/-/VDR-/- BMT and Rag-1 -/- BMT recipients, indicating that local RAS activation in macrophages contributes to the enhanced atherogenesis seen in Rag-1 -/-/VDR-/- BMT mice. Taken together, these observations provide evidence that macrophage VDR signaling, in part by suppressing the local RAS, inhibits atherosclerosis in mice.",
author = "Szeto, {Frances L.} and Reardon, {Catherine A.} and Dosuk Yoon and Youli Wang and Wong, {Kari E.} and Yunzi Chen and Juan Kong and Liu, {Shu Q.} and Ravi Thadhani and Getz, {Godfrey S.} and Li, {Yan Chun}",
year = "2012",
month = "7",
day = "1",
doi = "10.1210/me.2011-1329",
language = "English (US)",
volume = "26",
pages = "1091--1101",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "7",

}

Szeto, FL, Reardon, CA, Yoon, D, Wang, Y, Wong, KE, Chen, Y, Kong, J, Liu, SQ, Thadhani, R, Getz, GS & Li, YC 2012, 'Vitamin D receptor signaling inhibits atherosclerosis in Mice', Molecular Endocrinology, vol. 26, no. 7, pp. 1091-1101. https://doi.org/10.1210/me.2011-1329

Vitamin D receptor signaling inhibits atherosclerosis in Mice. / Szeto, Frances L.; Reardon, Catherine A.; Yoon, Dosuk; Wang, Youli; Wong, Kari E.; Chen, Yunzi; Kong, Juan; Liu, Shu Q.; Thadhani, Ravi; Getz, Godfrey S.; Li, Yan Chun.

In: Molecular Endocrinology, Vol. 26, No. 7, 01.07.2012, p. 1091-1101.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vitamin D receptor signaling inhibits atherosclerosis in Mice

AU - Szeto, Frances L.

AU - Reardon, Catherine A.

AU - Yoon, Dosuk

AU - Wang, Youli

AU - Wong, Kari E.

AU - Chen, Yunzi

AU - Kong, Juan

AU - Liu, Shu Q.

AU - Thadhani, Ravi

AU - Getz, Godfrey S.

AU - Li, Yan Chun

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Although vitamin D has been implicated in cardiovascular protection, few studies have addressed the role of vitamin D receptor (VDR) in atherosclerosis. Here we investigate the effect of inacti-vation of the VDR signaling on atherogenesis and the antiatherosclerotic mechanism of vitamin D. Low density lipoprotein receptor (LDLR)-/-/VDR-/- mice exhibited site-specific accelerated atherogenesis, accompanied by increases in adhesion molecules and proinflammatory cytokines in the aorta and cholesterol influx in macrophages. Macrophages showed marked renin up-regulation in the absence of VDR, and inhibition of renin by aliskiren reduced atherosclerosis in LDLR-/-/ VDR-/- mice, suggesting that the renin-angiotensin system (RAS) promotes atherosclerosis in the absence of VDR. LDLR-/- mice receiving LDLR-/-/VDR-/- BMT developed larger lesions than LDLR-/- BMT controls. Moreover, LDLR-/- mice receiving Rag-1 -/-/VDR-/- BMT, which were unable to generate functional T and B lymphocytes, still had more severe atherosclerosis than Rag-1 -/- BMT controls, suggesting a critical role of macrophage VDR signaling in atherosclerotic suppression. Aliskiren treatment eliminated the difference in lesions between Rag-1 -/-/VDR-/- BMT and Rag-1 -/- BMT recipients, indicating that local RAS activation in macrophages contributes to the enhanced atherogenesis seen in Rag-1 -/-/VDR-/- BMT mice. Taken together, these observations provide evidence that macrophage VDR signaling, in part by suppressing the local RAS, inhibits atherosclerosis in mice.

AB - Although vitamin D has been implicated in cardiovascular protection, few studies have addressed the role of vitamin D receptor (VDR) in atherosclerosis. Here we investigate the effect of inacti-vation of the VDR signaling on atherogenesis and the antiatherosclerotic mechanism of vitamin D. Low density lipoprotein receptor (LDLR)-/-/VDR-/- mice exhibited site-specific accelerated atherogenesis, accompanied by increases in adhesion molecules and proinflammatory cytokines in the aorta and cholesterol influx in macrophages. Macrophages showed marked renin up-regulation in the absence of VDR, and inhibition of renin by aliskiren reduced atherosclerosis in LDLR-/-/ VDR-/- mice, suggesting that the renin-angiotensin system (RAS) promotes atherosclerosis in the absence of VDR. LDLR-/- mice receiving LDLR-/-/VDR-/- BMT developed larger lesions than LDLR-/- BMT controls. Moreover, LDLR-/- mice receiving Rag-1 -/-/VDR-/- BMT, which were unable to generate functional T and B lymphocytes, still had more severe atherosclerosis than Rag-1 -/- BMT controls, suggesting a critical role of macrophage VDR signaling in atherosclerotic suppression. Aliskiren treatment eliminated the difference in lesions between Rag-1 -/-/VDR-/- BMT and Rag-1 -/- BMT recipients, indicating that local RAS activation in macrophages contributes to the enhanced atherogenesis seen in Rag-1 -/-/VDR-/- BMT mice. Taken together, these observations provide evidence that macrophage VDR signaling, in part by suppressing the local RAS, inhibits atherosclerosis in mice.

UR - http://www.scopus.com/inward/record.url?scp=84863318938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863318938&partnerID=8YFLogxK

U2 - 10.1210/me.2011-1329

DO - 10.1210/me.2011-1329

M3 - Article

C2 - 22638071

AN - SCOPUS:84863318938

VL - 26

SP - 1091

EP - 1101

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 7

ER -

Szeto FL, Reardon CA, Yoon D, Wang Y, Wong KE, Chen Y et al. Vitamin D receptor signaling inhibits atherosclerosis in Mice. Molecular Endocrinology. 2012 Jul 1;26(7):1091-1101. https://doi.org/10.1210/me.2011-1329